MbrlCatalogueTitleDetail

Do you wish to reserve the book?
Can CT-based radiomics signature predict KRAS/NRAS/BRAF mutations in colorectal cancer?
Can CT-based radiomics signature predict KRAS/NRAS/BRAF mutations in colorectal cancer?
Hey, we have placed the reservation for you!
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Can CT-based radiomics signature predict KRAS/NRAS/BRAF mutations in colorectal cancer?
Oops! Something went wrong.
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Title added to your shelf!
Title added to your shelf!
View what I already have on My Shelf.
Oops! Something went wrong.
Oops! Something went wrong.
While trying to add the title to your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Can CT-based radiomics signature predict KRAS/NRAS/BRAF mutations in colorectal cancer?
Can CT-based radiomics signature predict KRAS/NRAS/BRAF mutations in colorectal cancer?

Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
How would you like to get it?
We have requested the book for you! Sorry the robot delivery is not available at the moment
We have requested the book for you!
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Can CT-based radiomics signature predict KRAS/NRAS/BRAF mutations in colorectal cancer?
Can CT-based radiomics signature predict KRAS/NRAS/BRAF mutations in colorectal cancer?
Journal Article

Can CT-based radiomics signature predict KRAS/NRAS/BRAF mutations in colorectal cancer?

2018
Request Book From Autostore and Choose the Collection Method
Overview
ObjectivesTo investigate whether CT-based radiomics signature can predict KRAS/NRAS/BRAF mutations in colorectal cancer (CRC).MethodsThis retrospective study consisted of a primary cohort (n = 61) and a validation cohort (n = 56) with pathologically confirmed CRC. Patients underwent KRAS/NRAS/BRAF mutation tests and contrast-enhanced CT before treatment. A total of 346 radiomics features were extracted from portal venous-phase CT images of the entire primary tumour. Associations between the genetic mutations and clinical background, tumour staging, and histological differentiation were assessed using univariate analysis. RELIEFF and support vector machine methods were performed to select key features and build a radiomics signature.ResultsThe radiomics signature was significantly associated with KRAS/NRAS/BRAF mutations (P < 0.001). The area under the curve, sensitivity, and specificity for predicting KRAS/NRAS/BRAF mutations were 0.869, 0.757, and 0.833 in the primary cohort, respectively, while they were 0.829, 0.686, and 0.857 in the validation cohort, respectively. Clinical background, tumour staging, and histological differentiation were not associated with KRAS/NRAS/BRAF mutations in both cohorts (P>0.05).ConclusionsThe proposed CT-based radiomics signature is associated with KRAS/NRAS/BRAF mutations. CT may be useful for analysis of tumour genotype in CRC and thus helpful to determine therapeutic strategies.Key Points• Key features were extracted from CT images of the primary colorectal tumour.• The proposed radiomics signature was significantly associated with KRAS/NRAS/BRAF mutations.• In the primary cohort, the proposed radiomics signature predicted mutations.• Clinical background, tumour staging, and histological differentiation were unable to predict mutations.